Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kymera Therapeutics, Inc. | Chief Medical Officer | Common Stock | 95.5K | $4.4M | $46.10 | Jul 16, 2024 | Direct |
Kymera Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 22.9K | Jul 16, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
KYMR | Kymera Therapeutics, Inc. | Jul 15, 2024 | 7 | -$1.72M | 4 | Jul 16, 2024 | Chief Medical Officer |
KYMR | Kymera Therapeutics, Inc. | Mar 1, 2024 | 5 | -$140K | 4 | Mar 4, 2024 | Chief Medical Officer |
KYMR | Kymera Therapeutics, Inc. | Feb 27, 2024 | 3 | -$17.2K | 4 | Feb 29, 2024 | Chief Medical Officer |
KYMR | Kymera Therapeutics, Inc. | Feb 9, 2024 | 4 | -$1.54M | 4 | Feb 9, 2024 | Chief Medical Officer |
KYMR | Kymera Therapeutics, Inc. | Mar 1, 2023 | 4 | -$40.2K | 4 | Mar 3, 2023 | Chief Medical Officer |
KYMR | Kymera Therapeutics, Inc. | May 4, 2022 | 4 | $33.7K | 4 | May 4, 2022 | Chief Medical Officer |
KYMR | Kymera Therapeutics, Inc. | Mar 1, 2022 | 2 | $0 | 4 | Mar 3, 2022 | Chief Medical Officer |
KYMR | Kymera Therapeutics, Inc. | Nov 1, 2021 | 13 | -$3.51M | 4 | Nov 2, 2021 | Chief Medical Officer |